ArticlePsychotherapy and psychosomatics2021
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.
Chiara Gastaldon et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
66 papers cite itlatest 60 shown
this paperpooled ittrialcites it